SE446450B - Amidderivat av 5-pyrimidin-karbonsyror for anvendning vid psykiska besver, samt sett for deras framstellning - Google Patents
Amidderivat av 5-pyrimidin-karbonsyror for anvendning vid psykiska besver, samt sett for deras framstellningInfo
- Publication number
- SE446450B SE446450B SE7901493A SE7901493A SE446450B SE 446450 B SE446450 B SE 446450B SE 7901493 A SE7901493 A SE 7901493A SE 7901493 A SE7901493 A SE 7901493A SE 446450 B SE446450 B SE 446450B
- Authority
- SE
- Sweden
- Prior art keywords
- group
- och3
- symbols
- formula
- och
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7804921A FR2417506A1 (fr) | 1978-02-21 | 1978-02-21 | Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques utiles notamment dans le traitement des troubles du psychisme |
| FR7902286A FR2457286A2 (fr) | 1979-01-30 | 1979-01-30 | Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques, leur preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7901493L SE7901493L (sv) | 1979-08-22 |
| SE446450B true SE446450B (sv) | 1986-09-15 |
Family
ID=26220449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7901493A SE446450B (sv) | 1978-02-21 | 1979-02-20 | Amidderivat av 5-pyrimidin-karbonsyror for anvendning vid psykiska besver, samt sett for deras framstellning |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4250178A (ko) |
| JP (1) | JPS54130585A (ko) |
| AU (1) | AU526298B2 (ko) |
| CA (1) | CA1096868A (ko) |
| CH (1) | CH639078A5 (ko) |
| DE (1) | DE2906461A1 (ko) |
| ES (1) | ES477852A1 (ko) |
| GB (1) | GB2014984B (ko) |
| GR (1) | GR66581B (ko) |
| IT (1) | IT1113438B (ko) |
| LU (1) | LU80937A1 (ko) |
| NL (1) | NL7901333A (ko) |
| SE (1) | SE446450B (ko) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2133004B (en) * | 1982-11-04 | 1986-06-11 | Ici Plc | Process for the extraction of metal values and novel metal extractants |
| US4743605A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase |
| DE4425143A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Substituierte Pyrimidinverbindungen und deren Verwendung |
| EP0850228A1 (en) * | 1995-09-01 | 1998-07-01 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
| US5811428A (en) * | 1995-12-18 | 1998-09-22 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
| DE69828197T2 (de) * | 1997-10-27 | 2005-12-08 | Sumitomo Pharmaceuticals Co., Ltd. | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut |
| US7504396B2 (en) * | 2003-06-24 | 2009-03-17 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
| TW200827346A (en) * | 2006-11-03 | 2008-07-01 | Astrazeneca Ab | Chemical compounds |
| TW200836719A (en) * | 2007-02-12 | 2008-09-16 | Astrazeneca Ab | Chemical compounds |
| WO2009098501A1 (en) * | 2008-02-04 | 2009-08-13 | Astrazeneca Ab | Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid |
| CN102066335A (zh) * | 2008-04-22 | 2011-05-18 | 阿斯利康(瑞典)有限公司 | 取代的嘧啶-5-甲酰胺281 |
| AU2015315177A1 (en) * | 2014-09-10 | 2017-03-16 | Epizyme, Inc. | Substituted pyrrolidine carboxamide compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2789979A (en) * | 1954-09-22 | 1957-04-23 | Searle & Co | Basically substituted nu-alkyl-2-amino-4-hydroxy-5-pyrimidine carboxamides and salts thereof |
-
1979
- 1979-02-09 GR GR58323A patent/GR66581B/el unknown
- 1979-02-12 US US06/011,752 patent/US4250178A/en not_active Expired - Lifetime
- 1979-02-15 IT IT20206/79A patent/IT1113438B/it active
- 1979-02-19 LU LU80937A patent/LU80937A1/xx unknown
- 1979-02-19 CA CA321,796A patent/CA1096868A/en not_active Expired
- 1979-02-19 ES ES477852A patent/ES477852A1/es not_active Expired
- 1979-02-19 CH CH159879A patent/CH639078A5/fr not_active IP Right Cessation
- 1979-02-20 AU AU44392/79A patent/AU526298B2/en not_active Ceased
- 1979-02-20 JP JP1896279A patent/JPS54130585A/ja active Pending
- 1979-02-20 NL NL7901333A patent/NL7901333A/xx not_active Application Discontinuation
- 1979-02-20 SE SE7901493A patent/SE446450B/sv not_active IP Right Cessation
- 1979-02-20 DE DE19792906461 patent/DE2906461A1/de not_active Withdrawn
- 1979-02-20 GB GB7905890A patent/GB2014984B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU4439279A (en) | 1979-07-19 |
| GR66581B (ko) | 1981-03-27 |
| IT7920206A0 (it) | 1979-02-15 |
| NL7901333A (nl) | 1979-08-23 |
| GB2014984A (en) | 1979-09-05 |
| DE2906461A1 (de) | 1979-08-23 |
| US4250178A (en) | 1981-02-10 |
| IT1113438B (it) | 1986-01-20 |
| CH639078A5 (fr) | 1983-10-31 |
| CA1096868A (en) | 1981-03-03 |
| GB2014984B (en) | 1982-06-09 |
| SE7901493L (sv) | 1979-08-22 |
| LU80937A1 (fr) | 1979-10-29 |
| JPS54130585A (en) | 1979-10-09 |
| ES477852A1 (es) | 1979-08-01 |
| AU526298B2 (en) | 1983-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69516847T2 (de) | Chlorpyrimidine als zwischenprodukte | |
| DE3248160C2 (de) | 2-[4-[(4,4-Dialkyl-2,6-piperidindion-1-yl)-butyl]-1-piperazinyl]pyrimidine, Verfahren zu ihrer Herstellung und pharmazeutische Mittel, die diese Verbindungen enthalten | |
| DE60010234T2 (de) | 2-amino-6-anilino-purine und deren verwendung als arzneimittel | |
| DE69013607T2 (de) | Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung. | |
| DE69713402T2 (de) | Liganden des neuropeptids y | |
| DE60311272T2 (de) | Neue purin- oder pyrrolol(2,3-d)pyrimidin-2-carbonsäurenitrile zur behandlung von mit cysteinproteaseaktivität assoziierten krankheiten | |
| DE69304883T2 (de) | Xanthin Derivate | |
| SE446450B (sv) | Amidderivat av 5-pyrimidin-karbonsyror for anvendning vid psykiska besver, samt sett for deras framstellning | |
| MXPA06009132A (es) | Inhibidores de integrasa de vih. | |
| JP2002537300A5 (ko) | ||
| DE69130869T2 (de) | Xanthinderivate | |
| US9481649B2 (en) | Synthesis of a neurostimulative piperazine | |
| US6964960B2 (en) | Indoloquinazolinones | |
| US7176222B2 (en) | Syntheses of ureas | |
| DE69226590T2 (de) | Verfahren zur Herstellung von substituierten N-Aryl-1,2,4-Triazolopyrimidin-2-Sulfonamiden | |
| US20180179207A1 (en) | Process for the preparation of a xanthine-based compound | |
| DE69122427T2 (de) | Imidazonaphthyridinderivate | |
| WO2003039439A2 (de) | Deuterierte pyrazolopyrimidinone sowie diese verbindungen enthaltende arzneimittel | |
| JPH05117273A (ja) | 医薬化合物 | |
| EP0976742A1 (en) | A synthesis of furan sulfonamide compounds useful in the synthesis of IL-1 inhibitors | |
| EP0121490B1 (de) | Substituierte 6-Aryl-1,2,4-triazolo[4,3-b]pyridazine, ihre Herstellung und Verwendung | |
| SE443560B (sv) | Analogiforfarande for framstellning av 1-amino-legre alkyl-3,4-difenyl-1h-pyrazoler | |
| JPH0269476A (ja) | ピリミジン誘導体の製法 | |
| US6184382B1 (en) | Process for preparing N6-substituted adenosine derivatives | |
| DK152501B (da) | Fremgangsmaade til fremstilling af pyrrolooe1,2-aaapyrimidiner eller salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7901493-2 Effective date: 19870915 Format of ref document f/p: F |